LDT
KL-6
KL6
-
-
-
Krebs von den Lungen-6 (KL-6) reflects the formation of fibrotic lung disease and is a biomarker used to characterize the risk and severity of interstitial lung diseases (ILDs). KL-6 is also a prognostic biomarker in patients with surgically resected non-small cell lung cancer.